RAYMOND HELLER: Open Payments
NPI 1124137039 · SUPERIOR, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$311 in 18 payments from 10 companies in 2025. Trend: 2023 $105 · 2024 $459 · 2025 $311
Food & beverage: $311
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $86 |
| Gilead Sciences, Inc. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Lundbeck LLC | 2 | $36 |
| Abbott Laboratories | 1 | $21 |
| Exact Sciences Corporation | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
Products named: REXULTI, CAPLYTA, FREESTYLE LIBRE 3, Cologuard Collection Kit, Auvelity, EVENITY, Ozempic, MAVYRET.
Industry payments across NE — which companies pay providers there.
